Cargando…
Forecasting future prevalence of type 2 diabetes mellitus in Syria
BACKGROUND: Type 2 diabetes mellitus (T2DM) is increasingly becoming a major public health problem worldwide. Estimating the future burden of diabetes is instrumental to guide the public health response to the epidemic. This study aims to project the prevalence of T2DM among adults in Syria over the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673829/ https://www.ncbi.nlm.nih.gov/pubmed/23705638 http://dx.doi.org/10.1186/1471-2458-13-507 |
_version_ | 1782272282474840064 |
---|---|
author | Al Ali, Radwan Mzayek, Fawaz Rastam, Samer M Fouad, Fouad O’Flaherty, Martin Capewell, Simon Maziak, Wasim |
author_facet | Al Ali, Radwan Mzayek, Fawaz Rastam, Samer M Fouad, Fouad O’Flaherty, Martin Capewell, Simon Maziak, Wasim |
author_sort | Al Ali, Radwan |
collection | PubMed |
description | BACKGROUND: Type 2 diabetes mellitus (T2DM) is increasingly becoming a major public health problem worldwide. Estimating the future burden of diabetes is instrumental to guide the public health response to the epidemic. This study aims to project the prevalence of T2DM among adults in Syria over the period 2003–2022 by applying a modelling approach to the country’s own data. METHODS: Future prevalence of T2DM in Syria was estimated among adults aged 25 years and older for the period 2003–2022 using the IMPACT Diabetes Model (a discrete-state Markov model). RESULTS: According to our model, the prevalence of T2DM in Syria is projected to double in the period between 2003 and 2022 (from 10% to 21%). The projected increase in T2DM prevalence is higher in men (148%) than in women (93%). The increase in prevalence of T2DM is expected to be most marked in people younger than 55 years especially the 25–34 years age group. CONCLUSIONS: The future projections of T2DM in Syria put it amongst countries with the highest levels of T2DM worldwide. It is estimated that by 2022 approximately a fifth of the Syrian population aged 25 years and older will have T2DM. |
format | Online Article Text |
id | pubmed-3673829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36738292013-06-06 Forecasting future prevalence of type 2 diabetes mellitus in Syria Al Ali, Radwan Mzayek, Fawaz Rastam, Samer M Fouad, Fouad O’Flaherty, Martin Capewell, Simon Maziak, Wasim BMC Public Health Research Article BACKGROUND: Type 2 diabetes mellitus (T2DM) is increasingly becoming a major public health problem worldwide. Estimating the future burden of diabetes is instrumental to guide the public health response to the epidemic. This study aims to project the prevalence of T2DM among adults in Syria over the period 2003–2022 by applying a modelling approach to the country’s own data. METHODS: Future prevalence of T2DM in Syria was estimated among adults aged 25 years and older for the period 2003–2022 using the IMPACT Diabetes Model (a discrete-state Markov model). RESULTS: According to our model, the prevalence of T2DM in Syria is projected to double in the period between 2003 and 2022 (from 10% to 21%). The projected increase in T2DM prevalence is higher in men (148%) than in women (93%). The increase in prevalence of T2DM is expected to be most marked in people younger than 55 years especially the 25–34 years age group. CONCLUSIONS: The future projections of T2DM in Syria put it amongst countries with the highest levels of T2DM worldwide. It is estimated that by 2022 approximately a fifth of the Syrian population aged 25 years and older will have T2DM. BioMed Central 2013-05-25 /pmc/articles/PMC3673829/ /pubmed/23705638 http://dx.doi.org/10.1186/1471-2458-13-507 Text en Copyright © 2013 Al Ali et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Al Ali, Radwan Mzayek, Fawaz Rastam, Samer M Fouad, Fouad O’Flaherty, Martin Capewell, Simon Maziak, Wasim Forecasting future prevalence of type 2 diabetes mellitus in Syria |
title | Forecasting future prevalence of type 2 diabetes mellitus in Syria |
title_full | Forecasting future prevalence of type 2 diabetes mellitus in Syria |
title_fullStr | Forecasting future prevalence of type 2 diabetes mellitus in Syria |
title_full_unstemmed | Forecasting future prevalence of type 2 diabetes mellitus in Syria |
title_short | Forecasting future prevalence of type 2 diabetes mellitus in Syria |
title_sort | forecasting future prevalence of type 2 diabetes mellitus in syria |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673829/ https://www.ncbi.nlm.nih.gov/pubmed/23705638 http://dx.doi.org/10.1186/1471-2458-13-507 |
work_keys_str_mv | AT alaliradwan forecastingfutureprevalenceoftype2diabetesmellitusinsyria AT mzayekfawaz forecastingfutureprevalenceoftype2diabetesmellitusinsyria AT rastamsamer forecastingfutureprevalenceoftype2diabetesmellitusinsyria AT mfouadfouad forecastingfutureprevalenceoftype2diabetesmellitusinsyria AT oflahertymartin forecastingfutureprevalenceoftype2diabetesmellitusinsyria AT capewellsimon forecastingfutureprevalenceoftype2diabetesmellitusinsyria AT maziakwasim forecastingfutureprevalenceoftype2diabetesmellitusinsyria |